Biodelivery Sci Intl (BDSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
Cash Flows From Operating Activities | |||||
Net Income | 84,860 | 25,711 | -15,305 | -33,867 | 5,285 |
Depreciation Amortization | 7,424 | 7,519 | 8,827 | 5,897 | 6,118 |
Income taxes - deferred | -56,527 | 0 | 0 | 40 | -15,972 |
Accounts receivable | -8,717 | -9,360 | -25,163 | -4,640 | -5,884 |
Other Working Capital | -2,780 | -20,034 | 429 | -6,284 | -17,982 |
Other Operating Activity | 16,777 | 21,145 | 42,284 | 14,741 | -4,016 |
Operating Cash Flow | $41,037 | $24,981 | $11,072 | $-24,113 | $-32,451 |
Cash Flows From Investing Activities | |||||
PPE Investments | -6,872 | -13 | -30,764 | -112 | -11 |
Net Acquisitions | N/A | N/A | N/A | -1,951 | -5,853 |
Investing Cash Flow | $-6,872 | $-13 | $-30,764 | $-2,063 | $-5,864 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | -20,000 | N/A | -67,346 | N/A | N/A |
Common Stock Issued | 463 | 3,369 | 1,911 | -747 | 439 |
Common Stock Repurchased | -11,903 | -205 | 0 | N/A | N/A |
Other Financing Activity | 0 | 19,564 | 105,193 | 49,550 | 27,052 |
Financing Cash Flow | $-31,440 | $22,728 | $39,758 | $48,803 | $27,491 |
Beginning Cash Position | 111,584 | 63,888 | 43,822 | 21,195 | 32,019 |
End Cash Position | 114,309 | 111,584 | 63,888 | 43,822 | 21,195 |
Net Cash Flow | $2,725 | $47,696 | $20,066 | $22,627 | $-10,824 |
Free Cash Flow | |||||
Operating Cash Flow | 41,037 | 24,981 | 11,072 | -24,113 | -32,451 |
Capital Expenditure | -6,872 | -13 | -30,764 | -112 | -11 |
Free Cash Flow | 34,165 | 24,968 | -19,692 | -24,225 | -32,462 |